139 related articles for article (PubMed ID: 16105513)
41. In vivo monitoring of transfected DNA, gene expression kinetics, and cellular immune responses in mice immunized with a human NIS gene-expressing plasmid.
Son HY; Jeon YH; Chung JK; Kim CW
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):612-625. PubMed ID: 27612483
[TBL] [Abstract][Full Text] [Related]
42. Optimization of multimodal imaging of mesenchymal stem cells using the human sodium iodide symporter for PET and Cerenkov luminescence imaging.
Wolfs E; Holvoet B; Gijsbers R; Casteels C; Roberts SJ; Struys T; Maris M; Ibrahimi A; Debyser Z; Van Laere K; Verfaillie CM; Deroose CM
PLoS One; 2014; 9(4):e94833. PubMed ID: 24747914
[TBL] [Abstract][Full Text] [Related]
43. Comparison of Cerenkov luminescence imaging (CLI) and gamma camera imaging for visualization of let-7 expression in lung adenocarcinoma A549 Cells.
Yang W; Qin W; Hu Z; Suo Y; Zhao R; Ma X; Ma W; Wang T; Liang J; Tian J; Wang J
Nucl Med Biol; 2012 Oct; 39(7):948-53. PubMed ID: 22749186
[TBL] [Abstract][Full Text] [Related]
44. Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
Liu RS; Hsieh YJ; Ke CC; Chen FD; Hwu L; Wang FH; Hwang JJ; Chi CW; Lee CH; Yeh SH
Anticancer Res; 2009 Jan; 29(1):211-21. PubMed ID: 19331152
[TBL] [Abstract][Full Text] [Related]
45. Quantification of early adipose-derived stem cell survival: comparison between sodium iodide symporter and enhanced green fluorescence protein imaging.
Quach CH; Jung KH; Paik JY; Park JW; Lee EJ; Lee KH
Nucl Med Biol; 2012 Nov; 39(8):1251-60. PubMed ID: 22998839
[TBL] [Abstract][Full Text] [Related]
46. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
47. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose.
Haberkorn U; Kinscherf R; Kissel M; Kübler W; Mahmut M; Sieger S; Eisenhut M; Peschke P; Altmann A
Gene Ther; 2003 May; 10(9):774-80. PubMed ID: 12704416
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of [(18)F]tetrafluoroborate: a PET imaging agent for thyroid disease and reporter gene imaging of the sodium/iodide symporter.
Jauregui-Osoro M; Sunassee K; Weeks AJ; Berry DJ; Paul RL; Cleij M; Banga JP; O'Doherty MJ; Marsden PK; Clarke SE; Ballinger JR; Szanda I; Cheng SY; Blower PJ
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2108-16. PubMed ID: 20577737
[TBL] [Abstract][Full Text] [Related]
49. AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study.
Rad AM; Iskander AS; Janic B; Knight RA; Arbab AS; Soltanian-Zadeh H
BMC Biotechnol; 2009 Mar; 9():28. PubMed ID: 19327159
[TBL] [Abstract][Full Text] [Related]
50. (124)I-PET Assessment of Human Sodium Iodide Symporter Reporter Gene Activity for Highly Sensitive In Vivo Monitoring of Teratoma Formation in Mice.
Lehner S; Lang C; Kaissis G; Todica A; Zacherl MJ; Boening G; Spitzweg C; Herbach N; Franz WM; Krause BJ; Steinhoff G; Bartenstein P; Hacker M; David R
Mol Imaging Biol; 2015 Dec; 17(6):874-83. PubMed ID: 25896817
[TBL] [Abstract][Full Text] [Related]
51. Use of rhenium-188 for in vivo imaging and treatment of human cervical cancer cells transfected with lentivirus expressing sodium iodide symporter.
Zhang M; Shi S; Guo R; Miao Y; Li B
Oncol Rep; 2016 Oct; 36(4):2289-97. PubMed ID: 27573304
[TBL] [Abstract][Full Text] [Related]
52. Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter.
Gao XF; Zhou T; Chen GH; Xu CL; Ding YL; Sun YH
Asian J Androl; 2014; 16(1):120-3. PubMed ID: 24369144
[TBL] [Abstract][Full Text] [Related]
53. Gene therapy with sodium/iodide symporter in hepatocarcinoma.
Haberkorn U
Exp Clin Endocrinol Diabetes; 2001; 109(1):60-2. PubMed ID: 11573143
[TBL] [Abstract][Full Text] [Related]
54.
Meng Y; Liu H; Bian N; Gong J; Zhong X; Huang C; Liang W; Xu H
Exp Ther Med; 2018 Sep; 16(3):2208-2218. PubMed ID: 30186460
[TBL] [Abstract][Full Text] [Related]
55. Feasibility of a novel positive feedback effect of 131I-promoted Bac-Egr1-hNIS expression in malignant glioma through baculovirus: a comparative study with Bac-CMV-hNIS.
Guo R; Zhang R; Pan Y; Xu H; Zhang M; Liang S; Wang L; Zhang Y; Li B
Nucl Med Commun; 2011 May; 32(5):402-9. PubMed ID: 21386735
[TBL] [Abstract][Full Text] [Related]
56. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.
Cho JY; Shen DH; Yang W; Williams B; Buckwalter TL; La Perle KM; Hinkle G; Pozderac R; Kloos R; Nagaraja HN; Barth RF; Jhiang SM
Gene Ther; 2002 Sep; 9(17):1139-45. PubMed ID: 12170377
[TBL] [Abstract][Full Text] [Related]
57. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
Shi S; Zhang M; Guo R; Miao Y; Hu J; Xi Y; Li B
PLoS One; 2015; 10(1):e0116531. PubMed ID: 25621996
[TBL] [Abstract][Full Text] [Related]
58. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
[TBL] [Abstract][Full Text] [Related]
59. Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells.
Li W; Ain KB
Endocr Relat Cancer; 2010 Jun; 17(2):383-98. PubMed ID: 20228127
[TBL] [Abstract][Full Text] [Related]
60. Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model.
Ahn SJ; Jeon YH; Lee YJ; Lee YL; Lee SW; Ahn BC; Ha JH; Lee J
Cancer Gene Ther; 2010 Jul; 17(7):492-500. PubMed ID: 20186172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
